TGFB1 and amyotrophic lateral sclerosis: Although MSCs clinical trials for ALS have reported that MCP-1 and TGF-β in CSF might be related to stem cell efficacy,29 large-scale clinical trials have not yet been able to objectively evaluate the therapeutic efficacy of MSCs in treating ALS.